Researchers do not treat cholesterol and cardiovascular disease as linked by coincidence alone. The strongest judgment comes from several independent lines of evidence that point to cholesterol, especially LDL cholesterol, as a cause of disease.

Causation and not just association

When scientists link cholesterol to cardiovascular disease (CVD), they mean more than a statistical pattern. They ask whether raised cholesterol appears before disease, whether risk rises as cholesterol rises, whether the same pattern is found in many studies, and whether lowering cholesterol reduces disease.

A single study cannot prove causation by itself. People with high cholesterol may also differ in diet, physical activity, smoking, body mass, or age. These are confounding variables, so strong conclusions need multiple types of evidence that all point in the same direction.

Why timing matters

For a factor to be causal, exposure must come before the outcome. Prospective cohort studies are useful because cholesterol is measured first, then participants are followed for years to see who develops heart attacks, strokes, or other CVD events. This makes reverse causation less likely, because the disease has not already occurred when cholesterol is measured.

Observational evidence linking cholesterol and CVD

Large observational studies have shown that people with higher blood cholesterol tend to have higher rates of CVD. This applies to total cholesterol, but it is especially clear for LDL cholesterol.

Important patterns in the evidence include:

• a positive association between blood cholesterol and CVD risk

• a dose-response relationship, where higher LDL levels are linked to higher risk

• consistency across different countries, age groups, and study designs

• repeated findings in very large populations, which makes chance less likely

These patterns matter because causal factors often show a graded effect. If rising LDL is followed by rising CVD risk, that supports the idea that LDL is involved in the disease process rather than simply being an unrelated marker.

There is also biological plausibility. LDL can enter artery walls and contribute to plaque formation, which makes the statistical association more convincing as a causal one.

Initiation of atherosclerosis (fatty streak formation): LDL particles are retained beneath the endothelium, can become modified, and promote recruitment of monocytes that differentiate into macrophages. Macrophages take up modified LDL and become foam cells, creating an early lipid-rich lesion in the artery wall. This connects raised LDL to a concrete disease mechanism rather than a purely statistical association. Source

Genetic evidence

Another strong line of evidence comes from inherited conditions that produce very high LDL cholesterol from a young age. People with these conditions often develop CVD much earlier than expected. This is important because their raised LDL is present for many years, often before adult lifestyle factors could explain the difference.

Genetic evidence is powerful for two reasons:

• it reduces the likelihood that the association is caused only by lifestyle confounders

• it shows that long-term exposure to high LDL increases lifetime CVD risk

This supports the idea that LDL is not just linked to disease, but helps drive the disease process.

Intervention evidence

Some of the strongest evidence for causation comes from studies in which LDL cholesterol is deliberately lowered and disease outcomes are then measured. In randomized controlled trials, lowering LDL reduces the number of CVD events.

This matters because experimental evidence tests the factor directly:

• if LDL were only an innocent marker, lowering it would not be expected to reduce disease consistently

• if lowering LDL leads to fewer heart attacks or strokes, that supports a cause-and-effect relationship

The evidence is stronger when larger reductions in LDL are associated with larger reductions in risk. This again supports a dose-response pattern. It also shows that the relationship is not based only on observation; it is supported by intervention.

Total cholesterol and LDL cholesterol

Total cholesterol is still useful, because raised total cholesterol is often associated with increased CVD risk. However, total cholesterol is a broader measure and is less specific than LDL. Two people may have the same total cholesterol but different amounts of LDL cholesterol.

Because of this, evidence based specifically on LDL cholesterol is often more convincing than evidence based on total cholesterol alone. LDL is more directly linked to the disease process, so it gives a clearer picture of causal risk.

Interpreting causation in biology

Biological causation does not mean certainty. Not every person with high LDL develops CVD early, and some people with lower LDL still develop disease. That does not weaken the causal case. In biology, a causal factor often changes probability of disease, not whether disease happens in every individual.

Scientists therefore judge the cholesterol-CVD relationship by weighing several features together:

• association in observational studies

• temporal sequence, with cholesterol measured before disease develops

• dose-response relationships

• biological plausibility

• genetic evidence from inherited high LDL

• experimental evidence showing that lowering LDL reduces CVD events

This is why the evidence for a causal relationship is much stronger than a simple correlation, especially for LDL cholesterol.